INDP - Indaptus Therapeutics, Inc.

QQQ $ 445.88 $ 2.85 (0.64 %)

DIA $ 395.58 $ 1.12 (0.28 %)

SPY $ 523.16 $ 2.39 (0.46 %)

TLT $ 90.86 $ 0.51 (0.56 %)

GLD $ 218.12 $ 1.83 (0.85 %)

Previous Close

$ 2.13

Open

$ 2.14

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.14 - $ 2.14

52 Week Range

$ 1.56 - $ 4.08

Volume

2,328

Average Volume

Market Cap

17.98M

Beta (5Y Monthly)

$ 1.29

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
1	05-08-2024	03-31-2024	10-Q
2	03-13-2024	12-31-2023	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Indaptus Therapeutics Q1 EPS $(0.45) Misse...
05/08/2024 12:26:36

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate ...

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
05/02/2024 20:31:10

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
05/01/2024 20:31:24

HC Wainwright & Co. Reiterates Buy on Inda...
04/15/2024 10:08:24

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Indaptus Therapeutics (NASDAQ:INDP) with a Buy and maintains $...

Indaptus Therapeutics Unveils Details On M...
04/11/2024 11:35:20

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
04/05/2024 12:09:50

Indaptus Therapeutics Previews Mechanism O...
03/25/2024 12:41:26

Data demonstrates that Company's Decoy platform successfully induces or activates multiple immune celltypes involved in ant...

Indaptus Therapeutics: Q4 Earnings Insights
03/13/2024 13:40:12

Indaptus Therapeutics FY EPS $(1.83) Beats...
03/13/2024 11:39:27

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(1.83) per share which beat the analyst consensus estimate of...

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
03/11/2024 13:05:55

Indaptus Therapeutics Announces Results Fr...
03/04/2024 12:33:08

• Positive data following completion of second cohort of Phase 1 trial of Decoy 20 leads independent Safety Review Committee to...

why-butterfly-network-shares-are-trading-lower-by-22-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why Butterfly Network Shares Are Trading L...
02/29/2024 19:00:01

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed four...

Why Okta Shares Are Trading Higher By Arou...
02/29/2024 13:04:20

Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-e...

Indaptus Therapeutics Launches Social Medi...
02/08/2024 13:22:50

European Patent Office Approves Patent For...
01/04/2024 13:14:44

The patent, titled "Methods of Treatment of Infections Using Bacteria," (Application 19 866 580.4) provides protections...

Indaptus Therapeutics Q3 EPS $(0.47) Beats...
11/06/2023 22:32:59

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of...

why-bluegreen-vacations-shares-are-trading-higher-by-around-105-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Bluegreen Vacations Shares Are Trading...
11/06/2023 18:36:30

Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The c...

Indaptus Therapeutics Announces Interim Da...
11/06/2023 13:08:02

Indaptus Therapeutics To Present Pharmacod...
10/31/2023 13:17:54

Poster to be presented at 38th Annual Meeting of the Society for Immunotherapy of Cancer on November 4, 2023 NEW YORK, Oct. 31,...

HC Wainwright & Co. Reiterates Buy on Inda...
09/20/2023 10:32:36

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Indaptus Therapeutics (NASDAQ:INDP) with a Buy and maintains $...